Key takeaways for Nevada
- • No GLP-1 is FDA-approved for pre/post-bariatric use specifically.
- • Pre-op: liver shrinkage and risk optimization; post-op: regain management.
- • Observational data show 8-15% additional weight loss post-op on GLP-1.
- • Nevada Medicaid coverage rules apply for Bariatric Pre- and Post-Op Support patients in Nevada — see Medicaid section below.
- • 13 GLP-1 telehealth providers available nationwide.
Why GLP-1 medications for Bariatric Pre- and Post-Op Support
No GLP-1 is FDA-approved specifically for bariatric pre/post-op support. Off-label preoperative use can reduce liver volume and improve surgical access; off-label postoperative use addresses the roughly 25-30% of bariatric patients who experience clinically significant weight regain. Evidence grade: C (observational data growing; few RCTs). The ASMBS 2022 statement and emerging 2024-2025 consensus recognize this as an evolving practice. Pancreatitis and gastroparesis risks may merit extra caution in altered post-op anatomy.
Nevada-specific context
Nevada has telehealth access concentrated in Las Vegas, Henderson, Reno metros, with additional reach to North Las Vegas and Sparks. University Medical Center of Southern Nevada, Renown Health is the largest in-state academic medical center for endocrine + obesity-medicine specialty consults. The state health authority publishes prescribing + coverage updates at dhhs.nv.gov.
Nevadatelehealth & pricing rules
- • Nevada permits audio-only and asynchronous telehealth visits for GLP-1 care.
- • Nevada allows new-patient telehealth prescribing without a prior in-person visit.
- • Typical cash GLP-1 price in Nevada: ~$269/mo (compounded options often lower, brand higher).
State telehealth statutes change — verify current rules with your provider before booking.